Skip to main content

Ascendis Pharma A/S

ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612042

In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Ascendis Pharma A/S changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ASND: Q1 2021 compared with Q2 2021
MeasureQ1 2021Of which not filed for Q2 2021Q2 2021Change
Holders1772171−4
Shares52.9M11.5K55.0M+2.13M (+4.0%)
Value$6.83B$1.48M$7.24B+$412.1M (+6.0%)

2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Ascendis Pharma A/S at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ASND in Q2 2021
InstitutionSharesValue% of portfolio
Avoro Capital Advisors LLC1,900,000$249.9M4.35%
CIBC Asset Management Inc164,279$21.6M0.09%
Laurion Capital Management LP20,699$2.72M0.04%
Russell Investments Group, Ltd.20,241$2.66M0.00%
HRT Financial LP12,495$1.64M0.02%
Eqis Capital Management, Inc.10,046$1.32M0.10%
Squarepoint Ops LLC6,477$852.0K0.01%
SG3 Management, LLC4,000$526.0K0.22%
Baird Financial Group, Inc.3,000$395.0K0.00%
Profund Advisors LLC2,991$393.0K0.01%
SG Americas Securities, LLC2,527$332.0K0.00%
United Bank2,102$277.0K0.04%
Paloma Partners Management Co2,099$276.0K0.01%
Trexquant Investment LP2,042$269.0K0.02%
Prelude Capital Management, LLC2,000$263.0K0.01%
Virtu Financial LLC1,682$221.0K0.02%
Harbour Investments, Inc.192$25.0K0.00%
Parisi Gray Wealth Management167$22.0K0.01%
Bank Julius Baer & Co. Ltd, Zurich129$17.0K0.00%
Asset Management One Co.,Ltd.100$13.0K0.00%
Advisory Services Network, LLC82$11.0K0.00%
TFC Financial Management70$9.00K0.00%

Sold out (26)

Institutions that held Ascendis Pharma A/S at the end of Q1 2021 and filed for Q2 2021 without it.

Not filed for Q2 2021 yet (2)

Institutions that held Ascendis Pharma A/S at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASND in Q1 2021 that haven't filed for Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
OneAscent Wealth Management LLC7,868$1.01M
OneAscent Financial Services LLC3,646$470.0K